Form 4: Corcept Therapeutics Director Daniel N. Swisher Jr. Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Daniel N. Swisher Jr. of Corcept Therapeutics exercised stock options and sold the acquired shares on March 1, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 1, 2024, Daniel N. Swisher Jr., a director at Corcept Therapeutics, exercised stock options to acquire 2,200 shares of common stock at a price of $5.86 per share.
- Simultaneously, Swisher sold 2,200 shares of Corcept Therapeutics common stock at $23.59 per share.
- Following these transactions, Swisher directly owns 0 shares of Corcept Therapeutics common stock.
- Swisher also holds 8,950 derivative securities in the form of stock options.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction appears to be part of a pre-planned trading strategy (10b5-1 plan) and doesn't necessarily reflect a change in the director's outlook on the company.
Industry Context
Insider transactions are routinely monitored by investors to gauge management's perspective on the company's prospects. A sale of shares by a director may or may not indicate a negative outlook, especially when part of a pre-planned trading strategy.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock option exercise and sale of shares. |
| 03/05/2024 | Date of Form 4 filing. |
| 07/21/2026 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.